Coxsackie A Antibodies, CSF
Test Code
19895
86317 (x6)
Clinical Significance
Coxsackie A Antibodies, CSF
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Coxsackie Antibodies A2, A4, A7, A9, A10, A16
Methodology
Complement Fixation (CF)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
| Coxsackie A2 Ab | <1:1 titer |
| Coxsackie A4 Ab | <1:1 titer |
| Coxsackie A7 Ab | <1:1 titer |
| Coxsackie A9 Ab | <1:1 titer |
| Coxsackie A10 Ab | <1:1 titer |
| Coxsackie A16 Ab | <1:1 titer |
Interpretive Criteria
| <1:1 | Antibody Not Detected |
| ≥1:1 | Antibody Detected |
Preferred Specimen(s)
2 mL CSF
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
Reject Criteria
Gross hemolysis • Lipemia • Other types of body fluids • Grossly icteric
Setup Schedule
2 mL CSF
0.5 mL
Transport tube
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Gross hemolysis • Lipemia • Other types of body fluids • Grossly icteric